Garmin Venu 2 Plus ECG App unlocks long-awaited function in the United States
Electrocardiography-enabled wearables, more and more of which are also smartwatches intended for the general consumer market, are thought to make for a US$35.45 billion industry by 2027.
That may be part of the reason Garmin touted the Venu 2 Plus as an ECG-capable smartwatch on its launch; however, it required FDA approval prior to its activation.
Now, having secured that clearance, the OEM has unveiled its ECG App, the UI by which the Venu 2 Plus can use its cutting-edge function.
It can be used to record 30-second cardiograms and visualize them on the watch instantaneously, or sync them to their mobile device through Garmin Connect.
The OEM asserts that its new ECG App is capable of detecting atrial fibrillation (AFib) as well as offer a new kind of health-tracking in general.
Garmin does not go so far as to describe the Venu 2 Plus as a clinical device now, but does suggest that a user can gather ECG App data to help keep their doctor updated on their health status. It is available from now as a part of the wearable's v.11.21 software update.
Source(s)
